Angeion gets CE marking for Sentinel 2010:
This article was originally published in Clinica
Angeion can affix the CE marking to its Sentinel 2010 implantable cardioverter defibrillator, following review by TUV Product Services, Munich, Germany. The full-function, 60 cc, hot can device weighs 110 grams and is 16 mm thick. Unlike its predecessor the 2000, which was CE-marked in April, the 2010 features stored ECG. Angeion says it should have an active life of up to eight years.
You may also be interested in...
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.
The FDA has almost 30 decision dates coming up before New Year’s Eve, including nearly a dozen novel agents.